Mallika Imwong
Professor of Molecular Parasitology
- Honorary Visiting Research Fellow in Tropical Medicine
My research works have focused on three aspects:
- to understand how drug resistance emerges and spreads in malaria parasites in Asia and Africa
- to detect and characterise the true epidemiology of malaria in low transmissions setting
- to investigate the biology of relapse of benign malaria.
I am currently involved in surveillance studies describing the molecular epidemiology of drug resistance in different parts of the region including Thai-Burmese border, Eastern Thailand, Cambodia, Vietnam, Laos PDA, and Afghanistan. A key objective is to determine the genetic and mechanistic basis for increased resistance of P. falciparum to artemisinin. The development of an inexpensive and effective genetic tool is essential for public health monitoring for artemisinin resistance. My ongoing projects will use genotyping markers or phenotypic properties for the fitness cost alleviating genetic variants validated loci and conduct follow-up molecular epidemiological surveys to assess their prevalence throughout the GMS in the current state of transmission. Therefore, this will also allow us to assess the potential of the GMS to develop drug resistance phenotypes and to evaluate the potential that such phenotypes emerge in other parts of the malaria world (such as Africa), as control programs progress towards elimination.
Transnational spread of multidrug resistant PfPailin
Recent publications
Can malaria rapid diagnostic tests be used to detect simian malaria?
Journal article
Madmanee W. et al, (2025), Acta Tropica, 271
Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar
Journal article
Thu AM. et al, (2024), Malaria Journal, 23
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
Journal article
Siegel SV. et al, (2024), Nature Communications, 15
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Journal article
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Trio fluorophore-based phenotypic assay for the detection of artemisinin-induced growth-arrested Plasmodium falciparum in human erythrocytes
Journal article
Kobpornchai P. et al, (2024), Scientific Reports, 14
